Multi-modal probes for Magnetic Resonance and Radioactive Nuclide Imaging and Drug Delivery

The Portal is a joint project of MATTO and the MTTC. The development and implementation of the portal has been paid for by the MTTC, Beth Israel Deaconess Medical Center, Boston Biomedical Research Institute, Boston University, Brandeis University, Caritas St. Elizabeth's Medical Center, Boston Children's Hospital, Dana Farber Cancer Institute, Harvard University, Joslin Diabetes Center, Massachusetts Eye and Ear Infirmary, Massachusetts General Hospital, McLean Hospital, Northeastern University, The Schepens Eye Research Institute, and Tufts University.

Intellectual Property

ID:		UML 05-08
IP Type:		Licensable Technology
Title:		Multi-modal probes for Magnetic Resonance and Radioactive Nuclide Imaging and Drug Delivery
Inventor:		Arthur C. Watterson
Summary:		Prof. Watterson and co-researchers have developed and patented a revolutionary chemo-enzymatic “green” synthetic methodology for improving the current MRI technology. The patented methods pave the way for a new family of polymers which self-assemble in water to form nanospheres. These nanospheres can encapsulate drugs or contrast agents as MRI responsive cargo and deliver them to cellular systems, which specifically binds to cancer cells and is able to penetrate various types of cancer tumors.
Tech Type:		Nanotechnology/NEMS
URL:		http://www.uml.edu/cvip
Contact:		Susu Wong, 978 934 4722, susu_wong@uml.edu
Organization:		University of Massachusetts Lowell

Display all intellectual properties for Arthur C. Watterson
Display all intellectual properties for University of Massachusetts Lowell